Ganslev Christina A, Storebø Ole Jakob, Callesen Henriette E, Ruddy Rachel, Søgaard Ulf
Clinic of Liaison Psychiatry, Region Zealand, Denmark.
Psychiatric Research Unit, Psychiatry of Region Zealand, Slagelse, Denmark.
Cochrane Database Syst Rev. 2020 Jul 17;7(7):CD005331. doi: 10.1002/14651858.CD005331.pub3.
Conversion and dissociative disorders are conditions where people experience unusual neurological symptoms or changes in awareness or identity. However, symptoms and clinical signs cannot be explained by a neurological disease or other medical condition. Instead, a psychological stressor or trauma is often present. The symptoms are real and can cause significant distress or problems with functioning in everyday life for the people experiencing them.
To assess the beneficial and harmful effects of psychosocial interventions of conversion and dissociative disorders in adults.
We conducted database searches between 16 July and 16 August 2019. We searched Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, Embase, and eight other databases, together with reference checking, citation searching and contact with study authors to identify additional studies. SELECTION CRITERIA: We included all randomised controlled trials that compared psychosocial interventions for conversion and dissociative disorders with standard care, wait list or other interventions (pharmaceutical, somatic or psychosocial). DATA COLLECTION AND ANALYSIS: We selected, quality assessed and extracted data from the identified studies. Two review authors independently performed all tasks. We used standard Cochrane methodology. For continuous data, we calculated mean differences (MD) and standardised mean differences (SMD) with 95% confidence interval (CI). For dichotomous outcomes, we calculated risk ratio (RR) with 95% CI. We assessed and downgraded the evidence according to the GRADE system for risk of bias, imprecision, indirectness, inconsistency and publication bias.
We included 17 studies (16 with parallel-group designs and one with a cross-over design), with 894 participants aged 18 to 80 years (female:male ratio 3:1). The data were separated into 12 comparisons based on the different interventions and comparators. Studies were pooled into the same comparison when identical interventions and comparisons were evaluated. The certainty of the evidence was downgraded as a consequence of potential risk of bias, as many of the studies had unclear or inadequate allocation concealment. Further downgrading was performed due to imprecision, few participants and inconsistency. There were 12 comparisons for the primary outcome of reduction in physical signs. Inpatient paradoxical intention therapy compared with outpatient diazepam: inpatient paradoxical intention therapy did not reduce conversive symptoms compared with outpatient diazepam at the end of treatment (RR 1.44, 95% CI 0.91 to 2.28; 1 study, 30 participants; P = 0.12; very low-quality evidence). Inpatient treatment programme plus hypnosis compared with inpatient treatment programme: inpatient treatment programme plus hypnosis did not reduce severity of impairment compared with inpatient treatment programme at the end of treatment (MD -0.49 (negative value better), 95% CI -1.28 to 0.30; 1 study, 45 participants; P = 0.23; very low-quality evidence). Outpatient hypnosis compared with wait list: outpatient hypnosis might reduce severity of impairment compared with wait list at the end of treatment (MD 2.10 (higher value better), 95% CI 1.34 to 2.86; 1 study, 49 participants; P < 0.00001; low-quality evidence). Behavioural therapy plus routine clinical care compared with routine clinical care: behavioural therapy plus routine clinical care might reduce the number of weekly seizures compared with routine clinical care alone at the end of treatment (MD -21.40 (negative value better), 95% CI -27.88 to -14.92; 1 study, 18 participants; P < 0.00001; very low-quality evidence). Cognitive behavioural therapy (CBT) compared with standard medical care: CBT did not reduce monthly seizure frequency compared to standard medical care at end of treatment (RR 1.56, 95% CI 0.39 to 6.19; 1 study, 16 participants; P = 0.53; very low-quality evidence). CBT did not reduce physical signs compared to standard medical care at the end of treatment (MD -4.75 (negative value better), 95% CI -18.73 to 9.23; 1 study, 61 participants; P = 0.51; low-quality evidence). CBT did not reduce seizure freedom compared to standard medical care at end of treatment (RR 2.33, 95% CI 0.30 to 17.88; 1 trial, 16 participants; P = 0.41; very low-quality evidence). Psychoeducational follow-up programmes compared with treatment as usual (TAU): no study measured reduction in physical signs at end of treatment. Specialised CBT-based physiotherapy inpatient programme compared with wait list: no study measured reduction in physical signs at end of treatment. Specialised CBT-based physiotherapy outpatient intervention compared with TAU: no study measured reduction in physical signs at end of treatment. Brief psychotherapeutic intervention (psychodynamic interpersonal treatment approach) compared with standard care: brief psychotherapeutic interventions did not reduce conversion symptoms compared to standard care at end of treatment (RR 0.12, 95% CI 0.01 to 2.00; 1 study, 19 participants; P = 0.14; very low-quality evidence). CBT plus adjunctive physical activity (APA) compared with CBT alone: CBT plus APA did not reduce overall physical impacts compared to CBT alone at end of treatment (MD 5.60 (negative value better), 95% CI -15.48 to 26.68; 1 study, 21 participants; P = 0.60; very low-quality evidence). Hypnosis compared to diazepam: hypnosis did not reduce symptoms compared to diazepam at end of treatment (RR 0.69, 95% CI 0.39 to 1.24; 1 study, 40 participants; P = 0.22; very low-quality evidence). Outpatient motivational interviewing (MI) and mindfulness-based psychotherapy compared with psychotherapy alone: psychotherapy preceded by MI might decrease seizure frequency compared with psychotherapy alone at end of treatment (MD 41.40 (negative value better), 95% CI 4.92 to 77.88; 1 study, 54 participants; P = 0.03; very low-quality evidence). The effect on the secondary outcomes was reported in 16/17 studies. None of the studies reported results on adverse effects. In the studies reporting on level of functioning and quality of life at end of treatment the effects ranged from small to no effect.
AUTHORS' CONCLUSIONS: The results of the meta-analysis and reporting of single studies suggest there is lack of evidence regarding the effects of any psychosocial intervention on conversion and dissociative disorders in adults. It is not possible to draw any conclusions about potential benefits or harms from the included studies.
转换障碍和分离性障碍是指人们出现异常的神经症状或意识或身份改变的情况。然而,症状和临床体征无法用神经系统疾病或其他医学状况来解释。相反,往往存在心理应激源或创伤。这些症状是真实存在的,会给经历这些症状的人带来极大的痛苦,或导致日常生活功能出现问题。
评估心理社会干预对成人转换障碍和分离性障碍的有益和有害影响。
我们在2019年7月16日至8月16日期间进行了数据库检索。我们检索了Cochrane对照试验中心注册库(CENTRAL)、MEDLINE、Embase和其他八个数据库,并进行参考文献核对、引文检索以及与研究作者联系以识别其他研究。
我们纳入了所有将转换障碍和分离性障碍的心理社会干预与标准护理、等待名单或其他干预措施(药物、躯体或心理社会)进行比较的随机对照试验。
我们从纳入的研究中选择、进行质量评估并提取数据。两位综述作者独立完成所有任务。我们采用标准的Cochrane方法。对于连续性数据,我们计算了平均差(MD)和标准化平均差(SMD)以及95%置信区间(CI)。对于二分结局,我们计算了风险比(RR)以及95%CI。我们根据GRADE系统对证据的偏倚风险(risk of bias)、不精确性、间接性、不一致性和发表偏倚进行评估并降低证据等级。
我们纳入了17项研究(16项平行组设计和1项交叉设计),共894名年龄在18至80岁的参与者(女性与男性比例为3:1)。根据不同的干预措施和对照,数据被分为12个比较组。当评估相同的干预措施和对照时,研究被合并到同一比较组中。由于存在潜在的偏倚风险,证据的确定性被降低,因为许多研究的分配隐藏不清楚或不充分。由于不精确性、参与者数量少和不一致性,证据等级进一步降低。关于身体体征减轻这一主要结局有12个比较组。住院矛盾意向疗法与门诊地西泮相比:在治疗结束时,住院矛盾意向疗法与门诊地西泮相比并未减轻转换症状(RR 1.44,95%CI 0.91至2.28;1项研究,30名参与者;P = 0.12;极低质量证据)。住院治疗方案加催眠与住院治疗方案相比:在治疗结束时,住院治疗方案加催眠与住院治疗方案相比并未降低损伤严重程度(MD -0.4(负值更好),95%CI -1.28至0.30;1项研究,45名参与者;P = 0.23;极低质量证据)。门诊催眠与等待名单相比:在治疗结束时,门诊催眠与等待名单相比可能会降低损伤严重程度(MD 2.10(值越高越好),95%CI 1.34至2.86;1项研究,49名参与者;P < 0.00001;低质量证据)。行为疗法加常规临床护理与常规临床护理相比:在治疗结束时,行为疗法加常规临床护理与单独的常规临床护理相比可能会减少每周癫痫发作次数(MD -21.40(负值更好),95%CI -27.88至 -14. A92;1项研究,18名参与者;P < 0.00001;极低质量证据)。认知行为疗法(CBT)与标准医疗护理相比:在治疗结束时,CBT与标准医疗护理相比并未降低每月癫痫发作频率(RR 1.56,95%CI 0.39至6.19;1项研究,16名参与者;P = 0.53;极低质量证据)。在治疗结束时,CBT与标准医疗护理相比并未减轻身体体征(MD -4.75(负值更好),95%CI -18.73至9.23;1项研究,61名参与者;P = 0.51;低质量证据)。在治疗结束时,CBT与标准医疗护理相比并未提高无癫痫发作率(RR 2.33,95%CI 0.30至17.88;1项试验,16名参与者;P = 0.41;极低质量证据)。心理教育随访计划与常规治疗(TAU)相比:没有研究测量治疗结束时身体体征的减轻情况。基于CBT的专门住院物理治疗方案与等待名单相比:没有研究测量治疗结束时身体体征的减轻情况。基于CBT的专门门诊物理治疗干预与TAU相比:没有研究测量治疗结束时身体体征的减轻情况。简短心理治疗干预(心理动力人际治疗方法)与标准护理相比:在治疗结束时,简短心理治疗干预与标准护理相比并未减轻转换症状(RR 0.12,95%CI 0.01至2.00;1项研究,19名参与者;P = 0.14;极低质量证据)。CBT加辅助体育活动(APA)与单独的CBT相比:在治疗结束时,CBT加APA与单独的CBT相比并未降低总体身体影响(MD 5.60(负值更好),95%CI -15.48至26.68;1项研究,21名参与者;P = 0.60;极低质量证据)。催眠与地西泮相比:在治疗结束时,催眠与地西泮相比并未减轻症状(RR 0.69,95%CI 0.39至1.24;1项研究,40名参与者;P = 0.22;极低质量证据)。门诊动机性访谈(MI)和基于正念的心理治疗与单独的心理治疗相比:在治疗结束时,先进行MI的心理治疗与单独的心理治疗相比可能会降低癫痫发作频率(MD 41.40(负值更好),95%CI 4.92至77.88;1项研究,54名参与者;P = 0.03;极低质量证据)。16/17项研究报告了对次要结局的影响。没有研究报告不良反应的结果。在报告治疗结束时功能水平和生活质量的研究中,影响范围从小到无影响。
荟萃分析的结果和单项研究的报告表明,缺乏关于任何心理社会干预对成人转换障碍和分离性障碍影响的证据。从纳入的研究中无法得出关于潜在益处或危害的任何结论。